Endothelial Dysfunction Market to Reach $2.58Bn, Globally, by 2028 at 4.4% CAGR with Hypertension Segment Driving Growth During 2022-2028 | Report by The Insight Partners
August 11, 2023 06:41 ET
|
The Insight Partners
Pune, India, Aug. 11, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on “Endothelial Dysfunction Market Size Report & Share, Forecast to 2028 – COVID-19 Impact and...
HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion
August 08, 2023 11:54 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a reseller...
Avricore’s HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom
August 03, 2023 08:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased that HealthTab, the Company’s leading...
BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications
July 25, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
July 20, 2023 07:11 ET
|
BioSig Technologies, Inc.
Westport, CT, July 20, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Joins Webull Corporate Connect
June 29, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, June 29, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
June 27, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, June 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig to Highlight New Data from the PURE EP™ Platform at Heart Rhythm 2023
May 03, 2023 09:00 ET
|
BioSig Technologies, Inc.
Westport, CT, May 03, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
Artella Solutions, Inc. Announces Expansion into 6 States with New Leadership Team
April 28, 2023 16:10 ET
|
Artella Solutions, Inc.
HOUSTON, April 28, 2023 (GLOBE NEWSWIRE) -- via IBN -- Artella Solutions, Inc. (“ARTELLA”) today announces its proliferation into new regions that have the most opportunity to capture market share....
BioSig Announces New Advisory Board Member Edwin Wang
March 27, 2023 08:38 ET
|
BioSig Technologies, Inc.
Westport, CT, March 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...